Possibia

1197469

Last Update Posted: 2012-11-06

Recruiting has ended

All Genders

accepted

35 Years-85 Years

120 Estimated Participants

No Expanded Access

Interventional Study

Does not accept healthy volunteers

Do Phosphodiesterase 5A Inhibitors Improve Exercise Capacity in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Pulmonary Hypertension?

The investigators hypothesise that phosphodiesterase 5A inhibitors will improve exercise capacity in those with Chronic Obstructive Pulmonary Disease and secondary pulmonary hypertension.

Eligibility

Relevant conditions:

Chronic Obstructive Pulmonary Disease

Pulmonary Hypertension

If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.

locations

Contact Information

Overall Contact

No valid contacts available

Data sourced from ClinicalTrials.gov